Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001667404 | SCV001889024 | likely benign | not provided | 2018-10-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002538591 | SCV003274921 | likely benign | Long QT syndrome | 2022-11-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004039937 | SCV005036613 | likely benign | Cardiovascular phenotype | 2023-03-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003900842 | SCV004714203 | likely benign | KCNJ5-related disorder | 2022-04-05 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |